| [1] |
Charrez B, Qiao L, Hebbard L. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play[J]. World journal of gastroenterology, 2016, 22(8):2494-2502.
|
| [2] |
Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults[J]. Alimentary pharmacology & therapeutics, 2011, 34(3):274-285.
|
| [3] |
Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery[J]. Journal of hepatology, 2006, 45(4):600-606.
|
| [4] |
Sasaki A, Nitta H, Otsuka K, et al. Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments[J]. Frontiers in endocrinology, 2014, 5:164.
|
| [5] |
Jan A, Narwaria M, Mahawar KK. A Systematic Review of Bariatric Surgery in Patients with Liver Cirrhosis[J]. Obesity surgery, 2015, 25(8):1518-1526.
|
| [6] |
Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis[J]. Gastroenterology, 2015, 149(2):367-378.
|
| [7] |
Harrison SA, Fecht W, Brunt EM, et al. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial[J]. Hepatology (Baltimore, Md), 2009, 49(1):80-86.
|
| [8] |
McCarty TR, Echouffo-Tcheugui JB, Lange A, et al. Impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004-2012[J]. Surgery for obesity and related diseases: official journal of the American Society for Bariatric Surgery, 2018, 14(1):74-80.
|
| [9] |
Mathurin P, Hollebecque A, Arnalsteen L, et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease[J]. Gastroenterology, 2009, 137(2):532-540.
|
| [10] |
Lassailly G, Caiazzo R, Buob D, et al. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients[J]. Gastroenterology, 2015, 149(2):379-388.
|
| [11] |
Mummadi RR, Kasturi KS, Chennareddygari S, et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis[J]. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association, 2008, 6(12):1396-1402.
|
| [12] |
Bower G, Toma T, Harling L, et al. Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology[J]. Obesity surgery, 2015, 25(12):2280-2289.
|
| [13] |
Popov V, Emily Schonfeld, Kenneth Park, et al. The Impact of Bariatric Surgery on Liver Disease: A Systematic Review and Meta-Analysis[J]. American Journal Of Gastroenterology, 2016, 111(s1):350.
|
| [14] |
Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, et al. Bariatric surgery for non-alcoholic steatohepatitis in obese patients[J]. The Cochrane database of systematic reviews, 2010, (1):Cd007340.
|
| [15] |
von Schonfels W, Beckmann JH, Ahrens M, et al. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score) [J]. Surgery for obesity and related diseases: official journal of the American Society for Bariatric Surgery, 2018,14(10):1607-1616.
|
| [16] |
Froylich D, Corcelles R, Daigle C, et al. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study[J]. Surgery for obesity and related diseases: official journal of the American Society for Bariatric Surgery, 2016, 12(1):127-131.
|
| [17] |
Caiazzo R, Lassailly G, Leteurtre E, et al. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study[J]. Annals of surgery, 2014, 260(5):893-898.
|
| [18] |
Wu R, Ortiz J, Dallal R. Is bariatric surgery safe in cirrhotics[J]? Hepatitis monthly, 2013, 13(2):e8536.
|
| [19] |
Lazzati A, Audureau E, Hemery F, et al. Reduction in early mortality outcomes after bariatric surgery in France between 2007 and 2012: A nationwide study of 133,000 obese patients[J]. Surgery, 2016, 159(2):467-474.
|
| [20] |
Germanova D, Loi P, van Vyve E, et al, Closset J. Previous bariatric surgery increases postoperative morbidity after sleeve gastrectomy for morbid obesity[J]. Acta chirurgica Belgica, 2013, 113(4):254-257.
|
| [21] |
Goossens N, Hoshida Y, Song WM, et al. Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery[J]. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association, 2016, 14(11):1619-1628.
|
| [22] |
Ekstedt M, Hagstrom H, Nasr P, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up[J]. Hepatology (Baltimore, Md), 2015, 61(5):1547-1554.
|
| [23] |
Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease[J]. Gastroenterology, 2015, 149(2):389-397.
|
| [24] |
Takata MC, Campos GM, Ciovica R, et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation[J]. Surgery for obesity and related diseases: official journal of the American Society for Bariatric Surgery, 2008, 4(2):159-164.
|
| [25] |
Pestana L, Swain J, Dierkhising R, et al. Bariatric surgery in patients with cirrhosis with and without portal hypertension: a single-center experience[J]. Mayo Clinic proceedings, 2015, 90(2):209-215.
|
| [26] |
Kral JG, Thung SN, Biron S, et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis[J]. Surgery, 2004, 135(1):48-58.
|
| [27] |
Woodford RM, Burton PR, O'Brien PE, et al. Laparoscopic Adjustable Gastric Banding In Patients with Unexpected Cirrhosis: Safety and Outcomes[J]. Obesity surgery, 2015, 25(10):1858-1862.
|
| [28] |
Mosko JD, Nguyen GC. Increased perioperative mortality following bariatric surgery among patients with cirrhosis[J]. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association, 2011, 9(10):897-901.
|
| [29] |
Hanipah ZN, Punchai S, McCullough A, et al, Aminian A, et al. Bariatric Surgery in Patients with Cirrhosis and Portal Hypertension[J]. Obesity surgery, 2018, 28(11):3431-3438.
|
| [30] |
Goh GB, Schauer PR, McCullough AJ. Considerations for bariatric surgery in patients with cirrhosis[J]. World journal of gastroenterology, 2018, 24(28):3112-3119.
|
| [31] |
Heimbach JK, Watt KD, Poterucha JJ, et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease[J]. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2013, 13(2):363-368.
|
| [32] |
Lin MY, Tavakol MM, Sarin A, et al. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation[J]. Surgical endoscopy, 2013, 27(1):81-85.
|
| [33] |
Lazzati A, Iannelli A, Schneck AS, et al. Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery[J]. Obesity surgery, 2015, 25(1):134-142.
|
| [34] |
Osseis M, Lazzati A, Salloum C, et al. Sleeve Gastrectomy After Liver Transplantation: Feasibility and Outcomes[J]. Obesity surgery, 2018, 28(1):242-248.
|
| [35] |
Terjimanian MN, Harbaugh CM, Hussain A, et al. Abdominal adiposity, body composition and survival after liver transplantation[J]. Clinical transplantation, 2016, 30(3):289-294.
|
| [36] |
Singhal A, Wilson GC, Wima K, et al. Impact of recipient morbid obesity on outcomes after liver transplantation[J]. Transplant international: official journal of the European Society for Organ Transplantation, 2015, 28(2):148-155.
|
| [37] |
Cazzo E, Pareja JC, Chaim EA. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review[J]. Sao Paulo medical journal=Revista paulista de medicina, 2017, 135(3):277-295.
|
| [38] |
Duailibi DF, Ribeiro MA, Jr. Biliary complications following deceased and living donor liver transplantation: a review[J].Transplantation proceedings, 2010, 42(2):517-520.
|
| [39] |
Rogers CC, Alloway RR, Alexander JW, et al. Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study[J]. Clinical transplantation, 2008, 22(3):281-291.
|
| [40] |
Geerts A, Darius T, Chapelle T, et al. The multicenter Belgian survey on liver transplantation for hepatocellular failure after bariatric surgery[J]. Transplantation proceedings, 2010, 42(10):4395-4398.
|
| [41] |
Eilenberg M, Langer FB, Beer A, et al, Staufer K. Significant Liver-Related Morbidity After Bariatric Surgery and Its Reversal-a Case Series[J]. Obesity surgery, 2018, 28(3):812-819.
|
| [42] |
Hocking MP, Davis GL, Franzini DA, et al. Long-term consequences after jejunoileal bypass for morbid obesity[J]. Digestive diseases and sciences, 1998, 43(11):2493-2499.
|
| [43] |
Gan SK, Watts GF. Is adipose tissue lipolysis always an adaptive response to starvation?: implications for non-alcoholic fatty liver disease[J]. Clinical science, 2008, 114(8):543-545.
|
| [44] |
Truswell AS, Miller JC. Pathogenesis of the fatty liver in protein-energy malnutrition[J]. The American journal of clinical nutrition, 1993, 57(5):695-696.
|
| [45] |
Heimburger SL, Steiger E, Lo Gerfo P, et al. Reversal of severe fatty hepatic infiltration after intestinal bypass for morbid obesity by calorie-free amino acid infusion[J]. American journal of surgery, 1975, 129(3):229-235.
|
| [46] |
Gletsu-Miller N, Wright BN. Mineral malnutrition following bariatric surgery[J]. Advances in nutrition,2013, 4(5):506-517.
|
| [47] |
Prakash G, Drenick EJ, Wexler H, et al. Microbial flora in the bypassed jejunum of patients with biliopancreatic bypass for obesity[J]. The American journal of clinical nutrition, 1987, 46(2):273-276.
|
| [48] |
Sgambato D, Cotticelli G, de Sio I, et al. Liver failure in an obese middle-aged woman after biliointestinal bypass[J]. World journal of clinical cases, 2013, 1(1):52-55.
|
| [49] |
Holt PR. Changes in alcohol metabolism after gastric bypass surgery[J]. Lancet, 2011, 378(9793):767-768.
|
| [50] |
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease[J]. Journal of hepatology, 2016, 64(6):1388-1402.
|
| [51] |
De Luca M, Angrisani L, Himpens J, et al. Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)[J]. Obesity surgery, 2016, 26(8):1659-1696.
|
| [52] |
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases[J]. Hepatology (Baltimore, Md), 2018, 67(1):328-357.
|